BioAge Labs Management
Management criteria checks 2/4
BioAge Labs' CEO is Kristen Fortney, appointed in Apr 2015, has a tenure of 9.42 years. total yearly compensation is $1.38M, comprised of 35.7% salary and 64.3% bonuses, including company stock and options. directly owns 3.54% of the company’s shares, worth $25.41M. The average tenure of the management team and the board of directors is 3.7 years and 0.5 years respectively.
Key information
Kristen Fortney
Chief executive officer
US$1.4m
Total compensation
| CEO salary percentage | 35.7% |
| CEO tenure | 9.4yrs |
| CEO ownership | 3.5% |
| Management average tenure | 3.7yrs |
| Board average tenure | less than a year |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$62m |
| Mar 31 2024 | n/a | n/a | -US$66m |
| Dec 31 2023 | US$1m | US$493k | -US$64m |
Compensation vs Market: Kristen's total compensation ($USD1.38M) is below average for companies of similar size in the US market ($USD3.24M).
Compensation vs Earnings: Insufficient data to compare Kristen's compensation with company performance.
CEO
Kristen Fortney (41 yo)
9.4yrs
Tenure
US$1,382,720
Compensation
Dr. Kristen Fortney, PhD, serves as Member of Advisory Board at Known Medicine Inc. since April 2022. She co-founded BioAge Labs, Inc. in 2015 and serves as its Chief Executive Officer, President, Treasure...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 9.4yrs | US$1.38m | 3.54% $ 25.4m | |
| Co-Founder | 4.3yrs | US$872.80k | 0.20% $ 1.4m | |
| Chief Medical Officer & Executive VP of Research | 4.3yrs | US$840.83k | no data | |
| Chief Financial Officer | 2.8yrs | no data | 0.066% $ 470.5k | |
| Vice President of Finance & Accounting | 3.4yrs | no data | no data | |
| Senior Vice President of Research | no data | no data | no data | |
| Senior Vice President of People | 2.7yrs | no data | no data | |
| Chief Business Officer & Therapeutic Area Head of Brain Aging | 5.5yrs | no data | no data | |
| Senior Vice President of Regulatory Affairs | 4.7yrs | no data | no data | |
| Senior Vice President of Translational Aging Biology | 3.4yrs | no data | no data | |
| Chief Strategy Officer | 3.7yrs | no data | no data | |
| Chief Development Officer | 2.8yrs | no data | no data |
3.7yrs
Average Tenure
49.5yo
Average Age
Experienced Management: BIOA's management team is considered experienced (3.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 9.4yrs | US$1.38m | 3.54% $ 25.4m | |
| Co-Founder | 7.3yrs | US$872.80k | 0.20% $ 1.4m | |
| Independent Director | less than a year | no data | no data | |
| Independent Chairman of the Board | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 7.3yrs | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Independent Director | 3.1yrs | US$40.00k | 0% $ 0 | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
0.5yrs
Average Tenure
59yo
Average Age
Experienced Board: BIOA's board of directors are not considered experienced ( 0.5 years average tenure), which suggests a new board.